Search

The article offers information on same-day, bilateral cataract surgery, also known as immediately sequential bilateral cataract surgery (ISBCS), discussing its advantages such as enhanced patient convenience, reduced healthcare costs, and expedited visual rehabilitation. Topics include the potential benefits of ISBCS for patients, ophthalmologists, and the healthcare system, including quicker binocular vision recovery, increased surgeon efficiency, and decreased postoperative visits.

The article offers information on floaters, visual disturbances that can occur after cataract surgery and IOL implantation. Topics include changing attitudes towards floaters, with some experts considering them a disease that requires treatment. The article also discusses metrics developed to evaluate patients with floaters, such as ultrasound imaging to quantify vitreous density and contrast sensitivity measurements.

The article offers retina experts' explanation on how they approach cases of patients with both wet age-related macular degeneration (AMD) and geographic atrophy (GA). Topics covered include variance of treatment approaches among practitioners, a scenario involving a patient who has neovascularization and then develops GA and an expert view that active wet AMD needs to be treated and stabilized before considering GA treatment.

The article presents the discussion on challenges with medication compliance in cataract surgery patients. Topics include prompting some surgeons to adopt dropless or reduced-drops protocols to improve outcomes and alleviate cost burdens on patients; and strategies to improve patient adherence and technique in eye-drop administration.

The article focuses on managing complications that can arise from keratorefractive procedures like PRK, LASIK, and SMILE, emphasizing the importance of careful management and postoperative care. Topics include intraoperative complications such as flap-related issues and postoperative complications like over- and undercorrections, corneal haze, and dry eyes, with specific recommendations provided for addressing each complication to optimize visual outcomes.

The high cost of purchasing and administering vaccines has been a topic of discussion by pediatricians for some time. New vaccines cost much more than the older ones, and even [...]

The article focuses on comparing selective laser trabeculoplasty (SLT) with medication as first-line treatments for glaucoma. It discusses the advantages and disadvantages of each approach, including patient compliance, safety, efficacy, and long-term outcomes, drawing on recent clinical trials and expert opinions. It also mentions the considerations for choosing between SLT and medication based on factors such as disease severity, patient preferences, and cost-effectiveness.

The article focuses on the challenges and nuances of interpreting visual field tests in glaucoma patients, emphasizing the need to consider results in correlation with the overall patient examination. Topics include the complexities of visual field testing, challenges arising from patient cooperation and physiological factors, and expert tips for improving reliability, such as reviewing previous fields and utilizing virtual test options with language support.

The article focuses on the selection process for Minimally Invasive Glaucoma Surgery (MIGS), considering factors like the severity of glaucoma, intraocular pressure (IOP), and the number of medications the patient is using. It discusses various types of MIGS procedures, including canal-based, subconjunctival, and suprachoroidal options, emphasizing individualized approaches based on disease state and patient preferences to optimize safety and efficacy.

The article provides insights into the management of patients with damaged or congenitally malformed irises, discussing surgical techniques and lifelike artificial irises as potential solutions for addressing related issues such as photophobia, reduced vision, halo, and glare. Experienced surgeons share their approach to these challenging cases, emphasizing the importance of assessing iris damage, patient age, and the status of the natural lens when deciding on treatment options.

The article discusses the challenges in diagnosing dry eye disease (DED) and emphasizes the importance of evaluating both signs and symptoms for accurate diagnosis and treatment planning. It covers various grading criteria, such as the DEWS scale, which help classify the severity of DED based on clinical findings, and highlights the need for tailoring treatment approaches according to the severity of the condition.

The article focuses on the discussion surrounding office-based cataract surgery, highlighting its benefits such as patient comfort and cost savings, while also addressing safety concerns and potential drawbacks. The topics include the popularity of office-based surgery, safety considerations, patient experiences, surgeon perspectives, and potential complications associated with moving cataract surgery to office-based settings.

The article focuses on the latest techniques and technologies used in Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK) procedures. DMEK is typically preferred for patients with Fuchs' dystrophy, while DSAEK is reserved for more complex cases. It discusses tips and techniques for performing these procedures, including graft insertion methods and instruments used, as well as potential future advancements in corneal surgery.

The article presents the discussion on ophthalmologists getting creative to address staffing shortages. Topics include treating employees consistently and fairly, paying market rates, making it a fun place to work, and have good communication; and purchasing real estate to doing build outs for a new space, bringing new physicians.

The article discusses the use of dropless medication therapy in cataract surgery and its benefits and drawbacks. It also reviews a recent study from Denmark, as of March, 2023, that compared the effectiveness of topical nonsteroidal anti-inflammatory drugs, topical NSAIDs, and dropless surgery in controlling inflammation after cataract surgery.

The article focuses on how retina specialists handle recalcitrant wet age-related macular degeneration (AMD) that does not respond to initial anti-vascular endothelial growth factor (VEGF) treatment. Topics include the goal of managing neovascular AMD, starting treatment, and newer arrivals on the AMD scene such as Vabysmo.

The article presents the pipeline for diabetic macular edema treatments has expanded in recent years, with several promising products in various phases of clinical trials. Topics include the big news in DME treatment, however, is the FDA approval of Roche's Vabysmo in late January, and Vabysmo targets and inhibits two disease pathways linked to a number of vision-threatening retinal conditions by neutralizing angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A.

The article discusses the drawbacks of trabeculectomy (trabs) and tube surgery in terms of postoperative recovery. It highlight the Dr. Seibold notes that patients who undergo these procedures have a longer recovery time, as vision recovery can take months to stabilize and require more postoperative visits. It mentions the increase commitment in time and number of visits can also put patients at increased risk of serious complications such as endophthalmitis and hypotony.

The article offers information on the technological advancements associated with the eye surgery. It mentions that clear lens extraction or refractive lens exchange has gained popularity for the treatment of patients with high degrees of myopia, hyperopia and astigmatism who are unsuitable for laser refractive surgery.

The article presents that Refractive Surgery Council has reported the increase in the popularity of the laser vision correction procedures, specifically LASIK. It mentions that LASIK was approved by the U.S. Food and Drug Administration for use in 1995 and has remained at the forefront of refractive surgery since that time.

The article offers few procedures to help come through any unexpected event during cataract or retina surgery. It mentions importance of patient education and setting realistic expectations during surgery. It also importance of recognizing risk factors before that allows surgeons to modify surgical techniques to reduce the likelihood of this complication.

The article offers information on how to manage the complex dry-eye patient, along with explores the step to determine whether the correct diagnosis has been made. It mentions that next step as an exam that focuses on all parts of the eye and start with the eyelids to determine how easily meibum is expressed.

The article offers information on the primary angle-closure glaucoma which is affecting 20 million people worldwide and is a leading cause of irreversible blindness. It highlights a study which a low risk of an angle closure event when patients have anatomically narrow angles, so it may not be necessary to proceed with the prophylactic laser iridotomy; and mentions that the study is a randomized controlled trial in which bilateral primary angle-closure suspects aged 50 to 70 years.

The article discusses the factors being considered by glaucoma specialists when deciding on the procedures to be used for their patients, including disease severity and age. Also cited are the latest procedures to treat glaucoma like the Xen Glaucoma treatment system (Abbvie/Allergan) and PreserFlo Ab-Externo MicroShunt system from Santen, and the comments by specialists like Doctor Louis B. Cantor.

The article explores office-based cataract surgery offers several benefits over procedures performed in an ambulatory surgery center, and some surgeons believe this practice will become more common in the next few years. "From a big picture perspective, it's inevitable that we're going to be moving towards doing intraocular surgery in an office-based OR," says Omaha's Lance Kugler, MD.

The article offers a preview of the several devices and drugs to diagnosed dry-eye disease includes Visomitin from Mitotech, OC-01 from Oyster Point Pharmaceuticals, and NOV03 from Bausch Health.

The article offers tips and techniques on the use of phakic intraocular lenses (IOL). It discusses Ideal candidates for phakic IOL implantation are relatively young patients who have high myopia and are looking for good-quality vision. It discusses that Minneapolis surgeon David Hardten notes that patient education is important and to help patients understand the procedure, Hardten tells patients that the implant is like getting a contact lens implanted in their eye.

The article explores how surgeons need to manage inaccurate Intraocular lens calculations, an extended postop recovery time and patient expectations. Topics include lens calculations is the surgical procedure itself and the postoperative healing period are not routine in the eyes; and surgeons have had success with extended depth-of-focus lenses.